NASDAQ | ETF
The index uses a rules-based methodology that seeks to provide exposure to small-capitalizationU. S. companies with above average free cash flow margins.
Under normal circumstances, the fund will seek to invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities of small-capitalization companies ("small cap") that are principally traded in the United States.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DOCN | DigitalOcean Holdings Inc | Technology | Software - Infrastructure | 5.77% |
| VICR | Vicor Corporation | Technology | Electronic Components | 5.30% |
| IRDM | Iridium Communications Inc | Communication Services | Telecom Services | 4.58% |
| STRL | Sterling Construction Company Inc | Industrials | Engineering & Construction | 3.99% |
| POWI | Power Integrations Inc | Technology | Semiconductors | 3.15% |
| SMTC | Semtech Corporation | Technology | Semiconductors | 3.03% |
| ANF | Abercrombie & Fitch Company | Consumer Cyclical | Apparel Retail | 3.02% |
| POWL | Powell Industries Inc | Industrials | Electrical Equipment & Parts | 2.99% |
| HIMS | Hims Hers Health Inc | Consumer Defensive | Household & Personal Products | 2.69% |
| WIRE | Encore Wire Corporation | Industrials | Electrical Equipment & Parts | 2.58% |
| LQDA | Liquidia Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.49% |
| HCC | Warrior Met Coal Inc | Basic Materials | Coking Coal | 2.43% |
| ATEN | A10 Network | Technology | Software - Infrastructure | 2.42% |
| HWKN | Hawkins Inc | Basic Materials | Specialty Chemicals | 2.38% |
| US50012A1088 | KODIAK GAS SERVICES INC | 2.26% | ||
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 2.23% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 2.14% |
| AMN | AMN Healthcare Services Inc | Healthcare | Medical Care Facilities | 2.13% |
| MHO | M/I Homes Inc | Consumer Cyclical | Residential Construction | 2.11% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 2.09% |